mRNA-1010
- Generic Name
- mRNA-1010
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
- Conditions
- Seasonal Influenza
- Interventions
- Biological: Fluarix®Biological: Influsplit® TetraBiological: Fluarix TetraBiological: Alpharix® Tetra
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 56000
- Registration Number
- NCT06602024
- Locations
- 🇺🇸
Velocity Clinical Research-Savannah, Savannah, Georgia, United States
🇺🇸Javara - Privia Medical Group Georgia, LLC, Savannah, Georgia, United States
🇺🇸Clinical Research Atlanta/Headlands, Stockbridge, Georgia, United States
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults
- Conditions
- Influenza
- Interventions
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT05868382
- Locations
- 🇺🇸
DM Clinical Research, Sugar Land, Texas, United States
🇺🇸Meridian Clinical Research, Lincoln, Nebraska, United States
🇺🇸Johnson County Clin-Trials, Lenexa, Kansas, United States
A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults
- Conditions
- Seasonal Influenza
- Interventions
- Biological: mRNA-1010.2Biological: mRNA-1010.3
- First Posted Date
- 2023-04-24
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 698
- Registration Number
- NCT05827068
- Locations
- 🇺🇸
Healor Primary Care, Las Vegas, Nevada, United States
🇺🇸CenExel RCA, Hollywood, Florida, United States
🇺🇸Suncoast Research Associates, LLC, Miami, Florida, United States
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults
- Conditions
- Influenza
- Interventions
- Biological: Egg-based Quadrivalent Influenza VaccineBiological: Adjuvanted Quadrivalent Influenza VaccineBiological: Inactivated Influenza Vaccine
- First Posted Date
- 2022-11-07
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 325
- Registration Number
- NCT05606965
- Locations
- 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
- Conditions
- Seasonal Influenza
- Interventions
- Biological: mRNA-1010Biological: Licensed quadrivalent inactivated seasonal influenza vaccine
- First Posted Date
- 2022-10-04
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 22502
- Registration Number
- NCT05566639
- Locations
- 🇺🇸
Velocity Clinical Research - Westlake, Los Angeles, California, United States
🇺🇸CCT Research, Las Vegas, Nevada, United States
🇺🇸South Florida Research Center, Inc., Miami, Florida, United States
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
- Conditions
- Seasonal Influenza
- Interventions
- Biological: Fluarix Tetra
- First Posted Date
- 2022-06-13
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 6102
- Registration Number
- NCT05415462
- Locations
- 🇦🇷
Expertia S.A- Mautalen Salud e Investigacion, Ciudad Autónoma de Buenos Aires, Argentina
🇦🇷Instituto Médico Río Cuarto, Río Cuarto, Argentina
🇦🇺Emeritus Research, Camberwell, Australia
A Study of Modified mRNA Vaccines in Healthy Adults
- Conditions
- SARS-CoV-2Respiratory Syncytial VirusCytomegalovirusSeasonal Influenza
- Interventions
- First Posted Date
- 2022-05-31
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- ModernaTX, Inc.
- Target Recruit Count
- 308
- Registration Number
- NCT05397223
- Locations
- 🇺🇸
Johnson County Clinical Trials, Lenexa, Kansas, United States
🇺🇸Benchmark Research, Austin, Texas, United States
🇺🇸Tekton Research, Inc, Austin, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.